Alternative Splicing in Tumorigenesis and Cancer Therapy
Alternative splicing (AS) is a pivotal post-transcriptional mechanism that expands the functional diversity of the proteome by enabling a single gene to generate multiple mRNA and protein isoforms. This process, which involves the differential inclusion or exclusion of exons and introns, is tightly...
Saved in:
| Main Authors: | Huiping Chen, Jingqun Tang, Juanjuan Xiang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Biomolecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-273X/15/6/789 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Alternative splicing: A key regulator in T cell response and cancer immunotherapy
by: Caiyu Yong, et al.
Published: (2025-05-01) -
Identification of neoantigens derived from alternative splicing and RNA modification
by: Jiyeon Park, et al.
Published: (2019-08-01) -
Aging-related alternative splicing drive neoantigen emergence revealed by transcriptome analysis of 1,255 human blood samples
by: Shuhan Li, et al.
Published: (2025-05-01) -
Alternative splicing in ovarian cancer
by: Liwei Wei, et al.
Published: (2024-10-01) -
Best evidence linking the extracellular factor TGF-β to cancer-associated alternative splicing programs
by: Opeoluwa Alli-Oke, et al.
Published: (2025-01-01)